Table 3.

Logistic regression analysis to assess the relationship between demographic, epidemiological and clinical variables and severity of diseases (CIN2+) at baseline.

Variables		OR (95% IC)	p-Value
Age, years		1.01 (0.99–01.03)	0.49
Age groups, years	25–29	Ref	Ref
	30–34	1.67 (0.73–3.82)	0.22
	35–39	0.95 (0.38–2.33)	0.90
	40–44	1.00 (0.43–2.32)	0.99
	45–49	1.00 (0.42–2.38)	0.99
	50–54	1.76 (0.69–4.52)	0.24
	55–60	1.53 (0.51–4.54)	0.45
	>60	0.92 (0.20–4.29)	0.91
Positivity to HPV-DNA at baseline		1.29 (0.64–2.59)	0.48
Aged > 41 years		0.51 (0.31–0.86)	0.01
Education level	Elementary school	-	-
	Middle school	1.09 (0.54–2.21)	0.80
	High school	0.81 (0.44–1.50)	0.50
	Degree	0.39 (0.18–0.87)	0.02
Civil status	Married	0.96 (0.49–1.87)	0.91
Previous Abortion		0.87 (0.43–1.74)	0.69
Pre terms delivery		3.9 (0.4–38.2)	0.24
Parity		0.57 (0.34–0.96)	0.04
Menopause		0.77 (0.35–1.69)	0.51
Use of contraceptive		1.64 (0.58–4.65)	0.35
Gynaecological intervention before baseline		0.72 (0.21–2.53)	0.61
Vaccinated before baseline		1.13 (0.42–3.04)	0.80
Age at first dose vaccination		1.0 (0.97–1.03)	1.00
Co-infection at baseline		1.37 (0.82–2.30)	0.23
Familiarity for cancer	Uterus	1.30 (0.26–6.55)	0.75
	Ovary	-	-
	Breast	0.66 (0.32–1.36)	0.26
	Other gynaecological neoplasia	-	-